{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:07:36Z","timestamp":1779944856843,"version":"3.53.1"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy can be challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present the case report of a 33-year-old woman, diagnosed with diabetes since the age of 9. She had no micro or macrovascular complications, and HbA1c ranged between 6.5% and 6.8%, without pharmacological treatment. Family history revealed multiple relatives with the diagnosis of diabetes, including a maternal cousin with confirmed GCK-MODY. The patient underwent genetic testing that identified the variant NM_000162.5:c.829_830insCGG p.(Leu276_Val277insAla), heterozygous for the GCK gene, classified as of uncertain significance. During pregnancy, the couple chose not to undergo invasive fetal testing. Given the presumptive diagnosis of GCK-MODY and since fetal genotype was not determined, the pregnancy was managed under the assumption of a potentially unaffected fetus. During follow-up, combined with nutritional counseling and promotion of regular exercise, the patient required initiation of basal insulin therapy. Then, to optimize metabolic control, continuous glucose monitoring (CGM) was implemented, and insulin therapy was progressively intensified to a basal-bolus regimen, ultimately reaching eight daily bolus administrations of rapid-acting insulin. Adequate glycemic control and appropriate fetal growth were achieved, and she delivered a male newborn at 36 weeks and 2 days, with 2970g and APGAR score of 9 at 1, 5 and 10 minutes. Genetic testing of the mother and sister was requested during the patient\u2019s pregnancy, but the results became available only after delivery. These confirmed the presence of the same variant in both relatives, supporting the diagnosis of GCK-MODY.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the complexity of managing presumptive GCK-MODY during pregnancy, in the setting of a variant of uncertain significance and absent fetal genotyping. It emphasizes the importance of CGM-guided intensive insulin therapy and the need for a multidisciplinary and individualized approach based on shared decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1859312","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:59:44Z","timestamp":1779944384000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Ana Filipa","family":"Bolas","sequence":"first","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Hospital de Curry Cabral, Unidade Local de Sa\u00fade S\u00e3o Jos\u00e9","place":["Lisbon, Portugal"]},{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa","place":["Lisbon, Portugal"]},{"name":"Centro Cl\u00ednico Acad\u00e9mico de Lisboa","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Oliveira","family":"Torres","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Hospital de Curry Cabral, Unidade Local de Sa\u00fade S\u00e3o Jos\u00e9","place":["Lisbon, Portugal"]},{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa","place":["Lisbon, Portugal"]},{"name":"Centro Cl\u00ednico Acad\u00e9mico de Lisboa","place":["Lisbon, Portugal"]},{"name":"Faculdade de Medicina, Universidade de Lisboa","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bogalho","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Hospital de Curry Cabral, Unidade Local de Sa\u00fade S\u00e3o Jos\u00e9","place":["Lisbon, Portugal"]},{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa","place":["Lisbon, Portugal"]},{"name":"Centro Cl\u00ednico Acad\u00e9mico de Lisboa","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Silva-Nunes","sequence":"additional","affiliation":[{"name":"Endocrinology, Diabetes and Metabolism Department, Hospital de Curry Cabral, Unidade Local de Sa\u00fade S\u00e3o Jos\u00e9","place":["Lisbon, Portugal"]},{"name":"NOVA Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa","place":["Lisbon, Portugal"]},{"name":"Centro Cl\u00ednico Acad\u00e9mico de Lisboa","place":["Lisbon, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S179793","article-title":"Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment","volume":"12","author":"Urakami","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S186610","article-title":"Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives","volume":"12","author":"Rudland","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0065","article-title":"Monogenic diabetes: From genetic insights to population-based precision in care. Reflections from a Diabetes Care editors\u2019 expert forum","volume":"43","author":"Riddle","year":"2020","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06363-0","article-title":"Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities","volume":"68","author":"Ciangura","year":"2025","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad188","article-title":"Maternal and infant outcomes in GCK-MODY complicated by pregnancy","volume":"108","author":"Ren","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13860","article-title":"Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY)","volume":"13","author":"Tosur","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21110","article-title":"Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia","volume":"30","author":"Osbak","year":"2009","journal-title":"Hum Mutat"},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13059-023-02935-8","article-title":"A comprehensive map of human glucokinase variant activity","volume":"24","author":"Gersing","year":"2023","journal-title":"Genome Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s11658-024-00640-3","article-title":"Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis","volume":"29","author":"Abu Aqel","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1362977","article-title":"Management of pregnancy in women with monogenic diabetes due to mutations in GCK, HNF1A and HNF4A genes","volume":"15","author":"Crowley","year":"2024","journal-title":"Front Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136057","article-title":"Pregnancy and neonatal outcomes in maturity-onset diabetes of the young: a systematic review","volume":"26","author":"\u0141ugowski","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00125-023-05982-9","article-title":"Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing","volume":"66","author":"Hughes","year":"2023","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11892-018-0982-8","article-title":"Clinical management of women with monogenic diabetes during pregnancy","volume":"18","author":"Dickens","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20272","article-title":"ISUOG practice guidelines: ultrasound assessment of fetal biometry and growth","volume":"53","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.802423","article-title":"Pregnancy in women with monogenic diabetes due to pathogenic variants of the glucokinase gene: lessons and challenges","volume":"12","author":"Timsit","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1347290","article-title":"Enhancing fetal outcomes in GCK-MODY pregnancies: a precision medicine approach via non-invasive prenatal GCK mutation detection","volume":"11","author":"Schwitzgebel","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luaf147","article-title":"Continuous glucose monitoring in glucokinase-maturity-onset diabetes of the young pregnancy: a treatment paradigm change","volume":"3","author":"Gardner","year":"2025","journal-title":"JCEM Case Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1859312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:59:54Z","timestamp":1779944394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1859312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":17,"alternative-id":["10.3389\/fendo.2026.1859312"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1859312","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1859312"}}